The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Dissecting the genomic landscape of metastatic bladder cancer using circulating tumor DNA.
 
Werner J. Struss
No Relationships to Disclose
 
Gillian Vandekerkhove
No Relationships to Disclose
 
Matti Annala
No Relationships to Disclose
 
Tilman Todenhoefer
No Relationships to Disclose
 
Kevin Beja
No Relationships to Disclose
 
Bernhard J. Eigl
No Relationships to Disclose
 
Alexander William Wyatt
No Relationships to Disclose
 
Peter C. Black
Consulting or Advisory Role - Abbvie; Amgen; Astellas Pharma; Bayer; BioCancell; Biosyent; Cubist; Ferring; Janssen Oncology; Lilly; Merck; Novartis; Roche Canada; Sanofi; Sitka; Spectrum Pharmaceuticals
Speakers' Bureau - Ferring; Red Leaf Medical
Research Funding - iProgen; New B Innovation
Patents, Royalties, Other Intellectual Property - 1. PCT/CA2014/000787. Canada. 2014-11-03 Cancer Biomarkers and Classifiers and uses thereof. 2. #61899648 United States. 2013-03-13 Bladder cancer signature.
Travel, Accommodations, Expenses - Bayer; Janssen; Sanofi